Assessment of Clinical Trials Supporting US Food and Drug Administration Approval of Novel Therapeutic Agents, 1995-2017

IMPORTANCE: Since the introduction of the Fast Track designation in 1988, the number of special regulatory programs available for the approval of new drugs and biologics by the US Food and Drug Administration (FDA) has increased, offering the agency flexibility with respect to evidentiary requiremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Audrey D., Puthumana, Jeremy, Downing, Nicholas S., Shah, Nilay D., Krumholz, Harlan M., Ross, Joseph S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175081/
https://www.ncbi.nlm.nih.gov/pubmed/32315070
http://dx.doi.org/10.1001/jamanetworkopen.2020.3284

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7175081/
https://www.ncbi.nlm.nih.gov/pubmed/32315070
http://dx.doi.org/10.1001/jamanetworkopen.2020.3284

Ejemplares similares